Luxembourg, April 4, 2025 – Exobiosphere, the world’s first contract research organization dedicated to drug discovery in space, has raised over €2 million in a seed round.

The round was co-led by Expon Capital and Expansion Ventures.

“Space is not just the next frontier for exploration—it’s the next frontier for medicine,” said Kyle Acierno, CEO.